News and Reports
-
Paratek Pharmaceuticals completes $40 Million private placement to finance clinical programs including oral anti-MRSA antibiotics
16 April 2008Download -
Newron reports positive Phase II results for ralfinamide in peripheral neuropathic pain patients
16 April 2008Download -
BRAHMS AG: receives FDA clearance to market automated procalcitonin (PCT) test
7 April 2008Download -
ESBATech's antibody fragments demonstrate penetration into the eye with topical delivery via eye drops
25 February 2008Download -
Surface Logix reports phase 2A on SLX-4090
29 January 2008Download